Clinical trial
Prospective Study in the Use of the Alfapump® in the Treatment of Malignant Ascites
NCT04076566 is registered in ClinicalTrials.gov with Sequana Medical N.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study in the Use of the Alfapump® in the Treatment of Malignant Ascites
- Lead sponsor
- Sequana Medical N.V.
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- May 31, 2020
- Completion date
- March 31, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
malignant ascites